Quiz -Fear the Measles, Not the Shot: A seminar on Measles

Choose and encircle the letter of your best answer. Strictly NO ERASURES.
1. It is an act providing for mandatory basic immunization services for infants and
children.
a. RA 10512 c. RA 50121
b. RA 10152 d. RA 20152

2. Which of the following is NOT a clinical manifestation of measles?

a. Fever c. Koplik Spots
b. Conjuntivitis d. Vomiting

3. What is the virus that causes measles?

a. Paramyxovirus c. Hantavirus
b. Rhabdovirus d. Poliovirus

4. Which of these antiviral drugs are used in the treatment of measles?

a. Acyclovir c. Oseltamivir
b. Zanamivir d. None of the above

5. Among the major symptoms of measles, which of the following last the longest?
a. Koplik spots c. Cough
b. Rash d. fever

6. The measles rash

a. begins in the forehead, behind the ears and upper neck
b. begins in the upper neck, arms and abdomen
c. begins in the legs, abdomen and arms
d. None of the above
7. It is the most common cause of death in measles
a. Otitis media c. Pneumonia
b. Febrile Seizures d. Encephalitis
8. It is a chronic complication of measles that results from a persistent infection
with an altered measles virus that is harbored intracellularly in the CNS
a. SPPE c. SPEP
b. SSPE d. SSEP
9. What stage of progression shows symptoms of myoclonic jerks, seizures and
dementia?
a. Stage I c. Stage III
b. Stage II d. Stage IV

10. Vitamin A dosage for 6 months to 11 months of age

a. 50 000 IU c. 150 000 IU
b. 100 000 IU d. 200 000 IU
11. A measles supplemental Immunization activity for a measles-free Philippines
a Ligtas sa Tigdas ang Pilipinas
b Malaya sa Tigdas and Pilipinas
c Patayin ang Tigdas sa Pilipinas
d Malayo sa Tigdas and Pilipinas
12. The Goal of Expanded program on immunization is:
a. To reduce the morbidity and mortality among children against the most
common vaccine-preventable diseases.
b. To prevent the morbidity and mortality among children against the most
common vaccine-preventable diseases.
c. To eliminate the morbidity and mortality among children against the most
common vaccine-preventable diseases.
d. To decrease the morbidity and mortality among children against the most
common vaccine-preventable diseases.
13. Measles-Rubella Vaccine is given:
a. 0.05 ml intramuscular at Left Deltoid
b. 0.5 ml intramuscular at Left Deltoid
c. 0.5 ml subcutaneously at Left Deltoid
d. 0.05 ml subcutaneously at Left Deltoid
14. Measles containing vaccine should be
given within __ hours of exposure
a. 12 c. 48
b. 24 d. 72

15. Immunoglobulin may be given within

__ days after exposure
a. 2 c. 6
 b. 4 d. 8
16. The portal of entry of measles virus is through:
a. Respiratory Tract and Conjuntivae
b. Respiratory Tract and GI tract
c. GI Tract and Conjuntivae
d. None of the above

17. The first shot of MMR vaccine is given at

a. 4-6 months c. 8-12 months
b. 6-8 months d. 12-15 months

18. The second shot of MMR vaccine is given at

a. 2-4 years of age
b. 4-6 years of age
c. 6-8 years of age
d. 8-10 years of age

19. The commonly used vaccine against measles is

a. A killed vaccine
b. An inactivated vaccine
c. A toxoid
d. An attenuated weakened vaccine
20. In poor countries, most of the deaths from measles result from
a. The direct effect of the measles virus on the brain
b. A cytokine storm
c. Long-lasting immunosuppression due to the loss of B memory cells
d. Kidney failure